Results 81 to 90 of about 617,785 (192)

Development of Pharmaceutical Equivalent Montelukast Sodium Immediate-Release, Film-Coated Tablets

open access: yesScience and Technology Indonesia
Montelukast tablets are sold under the brand name Singulair and are used to control and prevent asthma symptoms. In this study, 10 mg film-coated montelukast tablets were developed as a generic drug in order to evaluate the pharmaceutical equivalent of ...
Poowadon Muenraya   +5 more
doaj   +3 more sources

Advancements in stability assessment: a novel method for impurity profiling in Montelukast and Fexofenadine dosage forms by RP-HPLC

open access: yesDiscover Chemistry
This study aims to develop and validate a specific, precise, and robust RP-HPLC method for the impurity profiling of Montelukast sodium and Fexofenadine in their combined tablet formulation.
Vikram S. Gharge   +6 more
doaj   +1 more source

Montelukast, a leukotriene receptor antagonist, in vernal keratoconjunctivitis associated with asthma

open access: yes, 2003
To evaluate the effects on signs and symptoms of a coexisting vernal keratoconjunctivitis in patients treated with oral montelukast sodium for ...
Bonini, Stefano   +5 more
core   +1 more source

Experimental study on montelukast sodium inducing apoptosis in multiple myeloma cells via targeting intracellular USP2 protein

open access: yesZhongguo aizheng zazhi
Background and purpose: Intracellular deubiquitylating enzymes, such as ubiquitin-specific peptidase 2 (USP2), play a pivotal role in regulating protein degradation and cellular homeostasis by modulating protein ubiquitin deconjugation, which have been ...
Chengrong DU   +5 more
doaj  

Attenuation of acute systemic inflammatory response after valve surgery

open access: yesJournal of Contemporary Medical Sciences, 2017
Objective This study highlights the protective effects of montelukast on myocardial ischemic reperfusion injury induced by cardiopulmonary bypass during valve replacement surgery.
Najah R. Hadi   +8 more
doaj  

MONTELUKAST AS ADD-ON THERAPY TO INHALED BECLOMETHASONE IN PERSISTENT BRONCHIAL ASTHMA

open access: yesPakistan Armed Forces Medical Journal, 2009
Objective: To evaluate the efficacy of Montelukast as add-on therapy in moderate persistent asthma with inadequate control on high dose inhaled beclomethasone. Study Design: A quasi experimental study.
Muhammad Babar Khan Khan   +4 more
doaj   +2 more sources

Effects of montelukast on tendon healing in a murine model

open access: yes, 2017
Background: Tendon injury induces a local inflammatory response characterized by the production of pro-inflammatory cytokines. The aim of this study is to investigate the effects of montelukast sodium on the healing of tendons through histological and ...
Bozdağ, Süreyya Ergün   +14 more
core   +1 more source

Montelukast medicines of today and tomorrow: from molecular pharmaceutics to technological formulations [PDF]

open access: yes, 2016
Montelukast sodium is a leukotriene antagonist of growing interest as an alternative therapy for asthma across different age groups due to its bronchoprotective, anti-inflammatory and anti-allergic properties.
Braga, Susana Santos   +2 more
core   +1 more source

Areverse Phase-Hplc/Uv Spectrophotometric Method for Estimation of Acebrophylline and Montelukast Sodium in Dosage forms. [PDF]

open access: yes, 2014
A simple, rapid, precise and highly selective Spectrophotometricmethod was developed for simultaneous estima tion of Montelukast sodium and Acebrophylline in tablet dosage form.
Kumar Naraharisetti, S
core  

Analytical Method Development and Validation of Montelukast Sodium and Fexofenadine Hydrochloride in Combined Tablet Dosage Form by UHPLC

open access: yes, 2021
A UHPLC method for Montelukast Sodium and Fexofenadine hydrochloride was developed and Validated in tablet dosage form as pre ICH Guide lines. UV visible Detector and Column C18(4.6mm × 50mm;1.8 microns)5μ is injected and eluted with the mobile phase of
Kanniyappan, C
core  

Home - About - Disclaimer - Privacy